SARS-CoV-2 diagnostic testing alternatives for Latin America
Main Article Content
In the past four months SARS-CoV-2 has reached most countries in the world. Public health strategies based on widespread testing and proper isolation of positive cases have shown to be helpful to reduce local transmission of SARS-CoV-2. Confirmatory tests, that identify viral RNA, and screening serological tests that identify viral antigens or host antibodies against viral proteins are part of the tools that nations can use to fight infectious disease epidemics. Understanding how each test works can provide insights about their test characteristics and how they can be used for different clinical and public health goals. Testing is a key strategy to reduce viral transmission, not only for this epidemic, but also for others to come.
- SARS-CoV-2
- diagnostic
- covid-19
- Severe Acute Respiratory Syndrome
- SARS Virus
- Virus RNA
- Coronavirus
- Quarantine
- RNA-Directed DNA Polymerase
- Viral Proteins
- Nucleocapsid
- Antibodies, Monoclonal
- Point-of-Care Systems
- Pandemics
- Indicators and Reagents
- Immobilized Proteins
Downloads
- Elvia Karina Grillo Ardila, Luis Eduardo Bravo Ocaña, Rodrigo Guerrero, Julián Santaella-Tenorio, Mathematical models and the coronavirus, COVID-19 , Colombia Medica: Vol. 51 No. 2 (2020): Coronavirus disease 2019
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The copy rights of the articles published in Colombia Médica belong to the Universidad del Valle. The contents of the articles that appear in the Journal are exclusively the responsibility of the authors and do not necessarily reflect the opinions of the Editorial Committee of the Journal. It is allowed to reproduce the material published in Colombia Médica without prior authorization for non-commercial use